close read more
Press release

Servier appoints a Chief Patient Officer


Servier appoints a Chief Patient Officer

Paris, 6 March 2018 – Servier today announced the arrival of Lode Dewulf as Chief Patient Officer. The creation of this position illustrates Servier’s resolve to act for and with the patient, through its Patient In strategy.

Lode Dewulf was the first to hold the position of Chief Patient Officer in the pharmaceutical industry, back in 2012, at UCB.

As part of his duties, Lode Dewulf’s main objectives is to coordinate, promote and develop Servier’s Patient In strategy in collaboration with patients and patient advocacy groups. Lode Dewulf reports to Olivier Laureau, President of Servier.

“Better informed, more involved and connected, patients are recognized as essential stakeholders and partners in therapeutic and medical advances”, declared Olivier Laureau, President of Servier.

The Patient In strategy is already underway at Servier. Several initiatives have been launched to facilitate the patient pathway and to empower patients to be involved in their own health care. These initiatives include the creation of age-appropriate information sheets for clinical trials, in collaboration with children with cancer, their parents, and medical professionals, and the writing of a patient’s guide to neurodegenerative diseases in conjunction with nonprofit organizations and universities, so as to encourage early screening for Alzheimer’s disease.

About Lode Dewulf

A Belgian national, Lode Dewulf holds a medical degree (Leuven, Belgium) and a diploma in pharmaceutical medicine (Leiden, Netherlands). He practiced medicine for two years before joining the pharmaceutical industry in 1989. He co-founded Planet Medica, the first European health care website, and collaborated from 2007 to 2017 with UCB where he served as Chief Patient Affairs Officer for 5 years.

In addition to these activities, Lode Dewulf continues to practice medicine pro bono.

Last press release

Press release
Servier appoints Angelo Paci as Oncology & Immuno-Oncology Program Leader
Press release
Servier appoints Nicolas Lévy as Chief Scientist Rare Diseases
Press release
Appointment of Walid S. Kamoun, PhD. MSc., Global Head of Servier R&D Oncology